Company
Every investor coverage indicates participated in a round Griffith University Institute for Biomedicine and Glycomics raised.
Companies Griffith University Institute for Biomedicine and Glycomics acquired or merged with, per published coverage. Buying a company is not investing in one: nothing here counts in the deals column.
| Name | Role | Sources |
|---|---|---|
| Professor Bernd Rehm | Principal Research Leader | @AuManufacturing |
Stories naming Griffith University Institute for Biomedicine and Glycomics. Where several outlets covered the same round, they are bundled under whichever ran the fullest account.
A South Australian biologics manufacturer will help scale a grant-backed university resin technology for purifying biopharmaceutical medicines from laboratory to commercial production.